Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Recurrence and MGMT[original query] |
|---|
| Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta neurochirurgica 2009 Nov 151 (11): 1349-58. Sonoda Yukihiko, Kumabe Toshihiro, Watanabe Mika, Nakazato Yoichi, Inoue Tomoo, Kanamori Masayuki, Tominaga Tei |
| MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. Journal of neuro-oncology 2011 Feb 101 (3): 405-17. Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M, Dinjens Winand N |
| O6-methylguanine-DNA methyltransferase gene coding region polymorphisms and oral cancer risk. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2010 Sep 39 (8): 645-50. Huang Sung-Hsien, Chang Pei-Yang, Liu Chung-Ji, Lin Ming-Wei, Hsia Kan-T |
| Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Annals of surgical oncology 2010 1 17 (7): 1767-76. Kim Jin C, Choi Jin S, Roh Seon A, Cho Dong H, Kim Tae W, Kim Yong |
| Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 18 (2): 585-92. Wagner Klaus W, Ye Yuanqing, Lin Jie, Vaporciyan Ara A, Roth Jack A, Wu Xife |
| Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2015 Sep 22 (9): 1425-9. Kong Doo-Sik, Kim Hong Rye, Choi Yoon-Ra, Seol Ho Jun, Lee Jung-Il, Nam Do-Hy |
| TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas. Oncotarget 2015 Nov . Gao Ke, Li Gang, Qu Yiping, Wang Maode, Cui Bo, Ji Meiju, Shi Bingyin, Hou Pe |
| Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
| Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma. Oncology letters 2015 Dec 10 (6): 3599-3606. Franceschi Sara, Mazzanti Chiara M, Lessi Francesca, Aretini Paolo, Carbone Francesco G, LA Ferla Marco, Scatena Cristian, Ortenzi Valerio, Vannozzi Riccardo, Fanelli Giovanni, Pasqualetti Francesco, Bevilacqua Generoso, Zavaglia Katia, Naccarato Antonio |
| TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-GE-180 PET study. European journal of nuclear medicine and molecular imaging 2019 9 47 (6): 1368-1380. Unterrainer M, Fleischmann D F, Vettermann F, Ruf V, Kaiser L, Nelwan D, Lindner S, Brendel M, Wenter V, Stöcklein S, Herms J, Milenkovic V M, Rupprecht R, Tonn J C, Belka C, Bartenstein P, Niyazi M, Albert N |
| Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival. Neurosurgery 2019 5 85 (5): E924-E932. Mistry Akshitkumar M, Kelly Patrick D, Gallant Jean-Nicolas, Mummareddy Nishit, Mobley Bret C, Thompson Reid C, Chambless Lola |
| Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma. Journal of neuro-oncology 2020 6 148 (3): 473-480. Shee Kevin, Chambers Meagan, Hughes Edward G, Almiron Damian A, Deharvengt Sophie J, Green Donald, Lefferts Joel A, Andrew Angeline S, Hickey William F, Tsongalis Gregory |
| High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting? Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 2 23 (7): 1358-1367. Gupta T, Maitre M, Maitre P, Goda J S, Krishnatry R, Chatterjee A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Jalali |
| Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2440-2448. Draaisma Kaspar, Tesileanu C Mircea S, de Heer Iris, Klein Martin, Smits Marion, Reijneveld Jaap C, Clement Paul M, de Vos Filip Y F, Wick Antje, Mulholland Paul J, Taphoorn Martin J B, Weller Michael, Chinot Olivier L, Kros Johan M, Verschuere Tina, Coens Corneel, Golfinopoulos Vassilis, Gorlia Thierry, Idbaih Ahmed, Robe Pierre A, van den Bent Martin J, French Pim |
| An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients. Anticancer research 2022 12 43 (1): 369-379. Furini Hector Hugo, Fukushima Kevin Santiago DE Souza Quenzo, DE Nóbrega Monyse, DE Souza Marilesia Ferreira, Rodrigues Milene Roldão Souza, DE Mattos Beatriz Bocatte, Guembarovski Roberta Losi, Fuganti Paulo Emílio, Simão Andrea Name Colado, Flauzino Tamires, Cólus Ilce Mara DE Syll |
| ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia. Genes 2023 7 14 (7): . Dhouha Jamai, Raja Gargouri, Boulbaba Selmi, Abdelmajid Khab |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: